Status:
UNKNOWN
A Prospective Randomized Controlled Trial on the Use of Cerebral Oximetry in Adult Chinese Patients Undergoing Liver Transplantation
Lead Sponsor:
The University of Hong Kong
Conditions:
Liver Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Liver transplantation (LT) is a life-saving procedure for patients with end-stage liver diseases. Although with continuous advancement in technology, it remains a high-risk operation. The goal of LT i...
Detailed Description
Liver Transplant Liver transplantation (LT) is a life-saving procedure for patients with end-stage liver disease. Despite continuous advancement in technology, it remains a high-risk operation. The bu...
Eligibility Criteria
Inclusion
- Able to get informed consent by patient
- Patients undergo DDLT or LDLT at Department of Surgery, Liver Transplant Centre, The University of Hong Kong, Queen Mary Hospital
- Ethnicity is Chinese
Exclusion
- Refusal of consent by patient
- Pre-existing neurological damage, history of seizures and on antidepressants
- Skin conditions over forehead that precludes the application of sensors of equipment
- Ethnicity is not Chinese
Key Trial Info
Start Date :
July 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2020
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT04122027
Start Date
July 30 2018
End Date
May 31 2020
Last Update
October 10 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, China
2
Queen mary Hospital
Hong Kong, Hong Kong